Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xen2174 single-dose study after bunionectomy surgery
2010-019109-40Phase 2Completed
- Sponsor
- Xenome Ltd
- Start
- Dec 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of Xen2174 in acute postoperative pain (3 arms), sponsored by Xenome Ltd. Primary endpoint: Area-under-the-curve of Numeric Rating Scale (NRS) pain. Started Dec 2010; status: completed.
02
Drugs
Xen2174
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on 2010-019109-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019109-40.